Intensive Phase
Determinants of Persistent Sputum Smear Positivity after Intensive Phase Chemotherapy among Patients with Tuberculosis at Rhodes Chest Clinic, Nairobi, Kenya
... after intensive phase of chemotherapy in people with ...of intensive phase TB chemotherapy and met inclusion ...months intensive phase were included in the ...
10
Sputum completion and conversion rates after intensive phase of tuberculosis treatment: an assessment of the Rwandan control program
... in a specified period that converted to smear negative status after the standard two months of the intensive phase of treatment. WHO recommends its use as a use- ful indicator for TB control programs in ...
7
Intensive-Phase Treatment Outcomes among Hospitalized Multidrug-Resistant Tuberculosis Patients: Results from a Nationwide Cohort in Nigeria
... the patients’’ [6]. Treatment success was associated with overall duration of treatment, number of effective drugs in the regimen, and with use of later generation fluoroquinolones (levofloxacin, moxifloxacin, ...
7
Evaluation of the Quality of Nutritional Management of Tuberculosis Patients under Treatment in the Intensive Phase in Two Benin Health Districts
... in intensive phase and twelve health professionals who provide care to TB patients identified by a reasoned ...of intensive phase treatment ...in intensive phase in the two ...
9
Substitution of ethambutol with linezolid during the intensive phase of treatment of pulmonary tuberculosis: study protocol for a prospective, multicenter, randomized, open label, phase II trial
... Development of a shorter duration anti-TB treatment regimen could improve not only treatment outcomes of individual patients but also TB control throughout the world. Based on higher culture conversion rates after 2 ...
8
Basavaraju
... Sputum smear positive (SSP) pulmonary tuberculosis patients are the most significant source of infection for tuberculosis. One untreated infectious tuberculosis patient is likely to infect 10 to 15 person annually. 5,6 ...
7
Effects of Dosage, Comorbidities, and Food on Isoniazid Pharmacokinetics in Peruvian Tuberculosis Patients
... continuation phase is based on in vitro studies, which have suggested that antituberculosis drugs, particularly INH, demon- strate a significant and prolonged postantibiotic effect which per- mits an extended ...
7
Risk factors for tuberculosis smear non conversion in Eden district, Western Cape, South Africa, 2007–2013: a retrospective cohort study
... of intensive phase ...of intensive phase of ...of intensive phase of treatment ...2-month intensive phase of ...
12
A case report of melioidosis complicated by infective sacroiliitis in Sri Lanka
... Her intensive phase was con- tinued with IV meropenem 2 g every 8 h another 6 weeks together with oral ...tensive phase treatment, she also developed Syndrome of Inappropriate Secretion of ADH ...
6
Development and validation of a prognostic score during tuberculosis treatment
... the intensive phase of the ...2-month intensive phase with four anti- tuberculosis [rifampicin (R), isoniazid (H), ethambutol (E) and pyrazinamide (Z)] and a 4-month continuation phase ...
9
Monocyte unresponsiveness and impaired IL1β, TNFα and IL7 production are associated with a poor outcome in Malawian adults with pulmonary tuberculosis
... 3 IL1β and TNFα production in response to stimulation with H37Rv and LPS immediately prior to the start of TB treatment and at the end of the intensive phase, in 6 patients who had a lif[r] ...
9
Delay in sputum smear conversion and outcomes of smear positive tuberculosis patients: a retrospective cohort study in Bafoussam, Cameroon
... the intensive phase is an indicator of TB program performance ...initial phase of ...the intensive phase of TB treatment range from 5% to 32% ...the intensive phase of TB ...
7
Non conversion of sputum culture among patients with smear positive pulmonary tuberculosis in Cameroon: a prospective cohort study
... In this study, the prevalence of multidrug resistant M. tuberculosis strains in patients with positive cultures was 4.3%. This prevalence is relatively high as compared to rates (0 to 2.7%) reported for patients with a ...
6
Vestibulo-otologic Events in Drug-resistant Tuberculosis Patients on Medications
... This is a prospective study of patients with drug resistant Tuberculosis who were admitted for the intensive phase of treatment with injectable medications at the DRTb center at Sacred Heart Hospital, ...
8
Association of serum chloride concentration with outcomes in postoperative critically ill patients: a retrospective observational study
... Background: Although chloride is one of the major electrolytes measured routinely in dairy practice, the amount of attention chloride receives in critically ill patients is limited. There are still a few studies ...
6
Biology and Clinical Applications of Hemopoietins in Pediatric Practice
... Phase I/Il study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer. Gabrilove JL, Jakubowski A, Fain K, e[r] ...
15
Single Window Ireland Facilitating our Trade : a vision for a new way to do Business
... • The Single Window Ireland system is aimed primarily at SMEs, and as such the system should be simple as possible to use. Comprehensive operating instructions and guidelines should be created for users. Help Desk and ...
10
Possible phosphorus losses from the top layer of agricultural soils by rainfall simulations in relation to multi nutrient soil tests
... long-term intensive applications of phosphoric fertilizers to soils and phosphorus recycling in farmyard manure caused the situation when the soil, originally a strong sink of phosphorus, became a source of its ...
8
Management of Tuberculosis: a handbook for clinicians
... continuation phase, the WHO recommendation would be for the patient to receive treatment for a total of 6 months (180 daily doses, or equivalent) by adding the lapsed period to the originally planned stopping ...
150
Recent drug approvals for acute myeloid leukemia
... randomized phase II Radius trial of midos- taurin versus standard of care following HSCT in patients with FLT3-ITD-mutated AML (NCT01883362) were recently reported, showing a trend toward increased 18- month ...
20